Literature DB >> 12559774

Endothelial nitric oxide synthase: the Cinderella of inflammation?

Giuseppe Cirino1, Stefano Fiorucci, William C Sessa.   

Abstract

A hallmark of inflammation is increased vascular permeability. Increases in vascular permeability and the migration of inflammatory cells are linked to complex interactions of inflammatory mediators with the vascular endothelium. Normally, endothelial nitric oxide synthase (eNOS) produces a tonic amount of nitric oxide (NO), which is responsible for the homeostasis between the endothelium and surrounding tissues. However, most agonists that act on endothelial cells cause a series of post-translational modifications that influence eNOS activity. Furthermore, stimulation by shear stress, autacoids or growth factors either induces eNOS or shifts it to a more active state, which produces a burst of NO. Here, we highlight recent findings about eNOS and propose how new pharmacological tools can be used to dissect the involvement and contribution of eNOS to inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559774     DOI: 10.1016/S0165-6147(02)00049-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  54 in total

Review 1.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

2.  Cinderology: the Cinderella of academic medicine.

Authors:  Lara Hazelton; Cathy Hickey
Journal:  CMAJ       Date:  2004-12-07       Impact factor: 8.262

3.  CFD analysis in an anatomically realistic coronary artery model based on non-invasive 3D imaging: comparison of magnetic resonance imaging with computed tomography.

Authors:  Leonid Goubergrits; Ulrich Kertzscher; Bastian Schöneberg; Ernst Wellnhofer; Christoph Petz; Hans-Christian Hege
Journal:  Int J Cardiovasc Imaging       Date:  2007-10-23       Impact factor: 2.357

4.  Edematogenic activity of scorpion venoms from the Buthidae family and the role of platelet-activating factor and nitric oxide in paw edema induced by Tityus venoms.

Authors:  D N Severino; R L Pereira; I Knysak; D M Cândido; F H Kwasniewski
Journal:  Inflammation       Date:  2009-02       Impact factor: 4.092

5.  Caveolin-1 scaffolding domain promotes leukocyte adhesion by reduced basal endothelial nitric oxide-mediated ICAM-1 phosphorylation in rat mesenteric venules.

Authors:  Sulei Xu; Xueping Zhou; Dong Yuan; Yanchun Xu; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

6.  Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium.

Authors:  Jessica L Lowry; Viktor Brovkovych; Yongkang Zhang; Randal A Skidgel
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

7.  The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production.

Authors:  Hong Wang; Aileen X Wang; Zhenqi Liu; Weidong Chai; Eugene J Barrett
Journal:  Mol Endocrinol       Date:  2009-07-16

8.  Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells.

Authors:  Chunying Li; Ling Ruan; Sarika G Sood; Andreas Papapetropoulos; David Fulton; Richard C Venema
Journal:  Vascul Pharmacol       Date:  2007-08-09       Impact factor: 5.773

9.  Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction.

Authors:  Feng Wu; John X Wilson
Journal:  Cardiovasc Res       Date:  2008-09-13       Impact factor: 10.787

10.  Nitric oxide synthase isoforms play distinct roles during acute peritonitis.

Authors:  Jie Ni; Rachel M McLoughlin; Alexandre Brodovitch; Pierre Moulin; Peter Brouckaert; Barbara Casadei; Olivier Feron; Nicholas Topley; Jean-Luc Balligand; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2009-08-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.